PUBLISHED ON: August 11, 2015 | Duration: 3 min, 51 sec
Biocon CMD Kiran Mazumdar-Shaw spoke to NDTV Profit on the occasion of Syngene's listing. She said the stock is rare and should command strong investor interest as now it is the only research service company listed in Asia after WuXi has decided to delist.
